We are live on ! Find out more
CCM

Chicago Capital Management Portfolio holdings

AUM $112M
1-Year Est. Return 76.54%
This Fund
S&P 500
This Quarter Est. Return
+10.44%
1 Year Est. Return
+76.54%
3 Year Est. Return
+294.65%
5 Year Est. Return
+1,991.46%
10 Year Est. Return
+177,846.73%
AUM
$121M
AUM Growth
-$26.2M
Cap. Flow
-$44.3M
Cap. Flow %
-36.69%
Top 10 Hldgs %
58.76%
Holding
43
New
8
Increased
3
Reduced
–
Closed
14

Top Buys

Rank Stock Value
1
GTLS
Chart Industries
GTLS
+$11M
2
ACLX
Arcellx
ACLX
+$8.2M
3
TERN
Terns Pharmaceuticals
TERN
+$5.31M
4
APLS
Apellis Pharmaceuticals
APLS
+$4.09M
5
FOLD
Amicus Therapeutics
FOLD
+$3.81M

Top Sells

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$8.17M
2
EXAS
Exact Sciences
EXAS
+$6.56M
3
CFLT
Confluent
CFLT
+$5.34M
4
ATXS
Astria Therapeutics
ATXS
+$5.24M
5
HOLX
Hologic
HOLX
+$4.78M

Sector Composition

Rank Sector Weight
1 Healthcare 21.81%
2 Financials 9.33%
3 Industrials 7.8%
4 Communication Services 0.25%
5 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNCR
26
DELISTED
Synchronoss Technologies
SNCR
– –
-182,470
Closed -$1.17M
DAY
27
DELISTED
Dayforce
DAY
– –
-34,568
Closed -$1.8M
1
2

Similar funds

PC
Parrish Capital Kennesaw, Georgia $112M AUM
VCM
Veradace Capital Management Dallas, Texas $112M AUM
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
APFP
Action Point Financial Planning Grand Rapids, Michigan $112M AUM
AIP
Arrowpoint Investment Partners Singapore $113M AUM 73.91% 1-Year Est. Return
GW
Graetz Wealth Jenison, Michigan $112M AUM
TBNY
Trustco Bank (New York) Albany, New York $113M AUM 34.59% 1-Year Est. Return
UOWF
University of Wisconsin Foundation Madison, Wisconsin $113M AUM 23.15% 1-Year Est. Return

Chicago Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Chicago Capital Management held 43 positions worth $121M, down 18% from $147M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Chicago Capital Management withdrew a net $44.3M in Q1 2026, closing 14 positions. Its most notable exit was Cidara Therapeutics, an estimated $8.17M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.

Against the trend, Chicago Capital Management opened a new position in Chart Industries worth $8.27M.

  • Chicago Capital Management's largest Q1 2026 buy was Chart Industries: 53,000 shares worth $8.27M.
  • Chicago Capital Management added most to Amicus Therapeutics in Q1 2026, an estimated $3.81M increase.
  • Chicago Capital Management fully exited Cidara Therapeutics in Q1 2026, selling an estimated $8.17M.
  • Chicago Capital Management's ten largest holdings make up 59% of its $121M portfolio in Q1 2026.
  • Chicago Capital Management opened 8 new positions and closed 14 in Q1 2026.
  • Chicago Capital Management's portfolio value fell 18% quarter-over-quarter to $121M.

Based on Chicago Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.